These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1594 related items for PubMed ID: 26781152

  • 1. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM, Grueneisen J, Schaarschmidt BM, Buchbender C, Nagarajah J, Umutlu L, Antoch G, Kinner S.
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2017 Apr; 89():14-19. PubMed ID: 28267530
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 18F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.
    Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L.
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):622-629. PubMed ID: 29164299
    [Abstract] [Full Text] [Related]

  • 4. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 5. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 6. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 7. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM, Grueneisen J, Buchbender C, Schaarschmidt BM, Gomez B, Ruhlmann V, Wetter A, Umutlu L, Antoch G, Heusch P.
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [Abstract] [Full Text] [Related]

  • 8. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V, Ruhlmann M, Bellendorf A, Grueneisen J, Sawicki LM, Grafe H, Forsting M, Bockisch A, Umutlu L.
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J, Beiderwellen K, Heusch P, Gratz M, Schulze-Hagen A, Heubner M, Kinner S, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L.
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ, Collado-Mesa F, Bokhoor J, Alperin N, Yepes MM.
    Breast J; 2014 Dec; 20(3):235-42. PubMed ID: 24750508
    [Abstract] [Full Text] [Related]

  • 11. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 12. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W.
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
    Taneja S, Jena A, Goel R, Sarin R, Kaul S.
    Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
    [Abstract] [Full Text] [Related]

  • 14. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT.
    Sawicki LM, Deuschl C, Beiderwellen K, Ruhlmann V, Poeppel TD, Heusch P, Lahner H, Führer D, Bockisch A, Herrmann K, Forsting M, Antoch G, Umutlu L.
    Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.
    Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K.
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1656-1665. PubMed ID: 26121928
    [Abstract] [Full Text] [Related]

  • 17. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [Abstract] [Full Text] [Related]

  • 18. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [Abstract] [Full Text] [Related]

  • 19. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
    Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L.
    PLoS One; 2017 Jul; 12(2):e0172553. PubMed ID: 28225831
    [Abstract] [Full Text] [Related]

  • 20. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, Nievelstein RA, de Klerk JM.
    AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.